Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Parkinson's Disease

Free Subscription 06.06.2022 1 Brain Res 1 J Neural Transm (Vienna) 2 Mov Disord 2 Neurobiol Dis 2 Neurologia (Engl Ed) 1 Neurology 1 Neuron 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain Res

1. ISHOLA IO, Awogbindin IO, Olubodun-Obadun TG, Oluwafemi OA, et al
   Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement.
   Brain Res. 2022 May 30:147958. doi: 10.1016/j.brainres.2022.147958.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

2. EKLUND M, Nuuttila S, Joutsa J, Jaakkola E, et al
   Diagnostic value of micrographia in Parkinson's disease: a study with [(123)I]FP-CIT SPECT.
   J Neural Transm (Vienna). 2022 May 27. pii: 10.1007/s00702-022-02517.
   PubMed         Abstract available
   
   

   
   Mov Disord

3. 
   The PSG 32nd Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders.
   Mov Disord. 2022;37 Suppl 1:S1-S36.
   PubMed        
   
   
4. HOBSON DE, Del Bigio MR
   Beekeeper Parkinsonism.
   Mov Disord. 2022 May 31. doi: 10.1002/mds.29076.
   PubMed        
   
   

   
   Neurobiol Dis

5. VOIGT RM, Wang Z, Brown JM, Engen PA, et al
   Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
   Neurobiol Dis. 2022 May 30:105780. doi: 10.1016/j.nbd.2022.105780.
   PubMed         Abstract available
   
   
6. SONG B, Feldmann JW, Cao S, Feitosa M, et al
   A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
   Neurobiol Dis. 2022 May 27:105777. doi: 10.1016/j.nbd.2022.105777.
   PubMed         Abstract available
   
   

   
   Neurologia (Engl Ed)

7. FERNANDEZ-ESPEJO E
   Microorganisms associated with increased risk of Parkinson's disease.
   Neurologia (Engl Ed). 2022 May 26. pii: S2173-5808(22)00054.
   PubMed         Abstract available
   
   
8. FERNANDEZ-PAJARIN G, Sesar A, Jimenez-Martin I, Ares B, et al
   Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson's disease.
   Neurologia (Engl Ed). 2022 May 26. pii: S2173-5808(22)00055.
   PubMed         Abstract available
   
   

   
   Neurology

9. TALMAN L
   Quality of Life for Patients With Parkinson Disease.
   Neurology. 2022;98:e2293-e2295.
   PubMed        
   
   

   
   Neuron

10. PANICKER N, Kam TI, Wang H, Neifert S, et al
    Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
    Neuron. 2022 May 25. pii: S0896-6273(22)00450.
    PubMed         Abstract available
    
    

    
    Rev Neurol

11. FERNANDEZ-PAJARIN G, Martin-Jimenez I, Ares-Pensado B, Sesar-Ignacio A, et al
    [Apomorphine and frontal dysfunction in Parkinson's disease].
    Rev Neurol. 2022;74:367-371.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: